Therma Bright Inc (THRM) - Cash Flow Conversion Efficiency

Latest as of October 2025: 0.026x

Based on the latest financial reports, Therma Bright Inc (THRM) has a cash flow conversion efficiency ratio of 0.026x as of October 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CA$-38.76K ≈ $-28.04K USD) by net assets (CA$-1.52 Million ≈ $-1.10 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see Therma Bright Inc stock valuation for the company's overall valuation and market capitalisation.

Therma Bright Inc - Cash Flow Conversion Efficiency Trend (2001–2025)

This chart illustrates how Therma Bright Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Therma Bright Inc Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Therma Bright Inc ranked by their cash flow conversion efficiency. Explore how high is Therma Bright Inc's earnings quality to measure how well operating cash flow supports reported net income.

Company Cash Flow Conversion Efficiency
KINGS ENTERTAINMENT GROUP
F:L12
N/A
Altech Batteries Ltd
AU:ATC
-0.199x
Jaguar Animal Health Inc
NASDAQ:JAGX
-1.085x
Filament Health Corp
NEO:FH
-0.228x
Genel Energy Plc
LSE:GENL
-0.014x
TECIL Chemicals and Hydro Power Limited
NSE:TECILCHEM
N/A
Prostemics Co. Ltd
KQ:203690
-0.036x
Savannah Resources Plc
LSE:SAV
-0.033x

Annual Cash Flow Conversion Efficiency for Therma Bright Inc (2001–2025)

The table below shows the annual cash flow conversion efficiency of Therma Bright Inc from 2001 to 2025. View THRM stock price and chart for real-time trading data and today's change.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-07-31 CA$-1.57 Million
≈ $-1.13 Million
CA$-146.53K
≈ $-106.00K
0.094x +112.28%
2024-07-31 CA$1.32 Million
≈ $958.00K
CA$-1.01 Million
≈ $-730.10K
-0.762x +98.43%
2023-07-31 CA$44.79K
≈ $32.40K
CA$-2.17 Million
≈ $-1.57 Million
-48.555x -3410.13%
2022-07-31 CA$2.75 Million
≈ $1.99 Million
CA$-3.80 Million
≈ $-2.75 Million
-1.383x +36.29%
2021-07-31 CA$1.32 Million
≈ $951.41K
CA$-2.86 Million
≈ $-2.07 Million
-2.171x -363.35%
2020-07-31 CA$223.97K
≈ $162.01K
CA$-104.94K
≈ $-75.91K
-0.469x -170.73%
2019-07-31 CA$-286.40K
≈ $-207.18K
CA$-189.72K
≈ $-137.24K
0.662x -86.82%
2018-07-31 CA$-71.59K
≈ $-51.79K
CA$-359.89K
≈ $-260.34K
5.027x +2417.45%
2017-07-31 CA$-893.85K
≈ $-646.59K
CA$-178.49K
≈ $-129.11K
0.200x +601500.19%
2016-07-31 CA$-1.63 Million
≈ $-1.18 Million
CA$54.00
≈ $39.06
0.000x -100.22%
2015-07-31 CA$-1.42 Million
≈ $-1.03 Million
CA$-21.43K
≈ $-15.50K
0.015x +50.83%
2014-07-31 CA$-5.52 Million
≈ $-3.99 Million
CA$-55.16K
≈ $-39.90K
0.010x -33.21%
2013-07-31 CA$-5.62 Million
≈ $-4.06 Million
CA$-84.10K
≈ $-60.84K
0.015x +22658.84%
2012-07-31 CA$-6.61 Million
≈ $-4.78 Million
CA$-435.00
≈ $-314.67
0.000x -97.60%
2011-07-31 CA$-5.83 Million
≈ $-4.22 Million
CA$-16.00K
≈ $-11.57K
0.003x -78.02%
2009-07-31 CA$-5.03 Million
≈ $-3.64 Million
CA$-62.68K
≈ $-45.34K
0.012x -87.91%
2008-07-31 CA$-3.54 Million
≈ $-2.56 Million
CA$-365.58K
≈ $-264.45K
0.103x -61.80%
2007-07-31 CA$-2.00 Million
≈ $-1.44 Million
CA$-539.12K
≈ $-389.99K
0.270x -69.93%
2006-07-31 CA$-1.46 Million
≈ $-1.06 Million
CA$-1.31 Million
≈ $-950.53K
0.898x +73.98%
2005-07-31 CA$-991.06K
≈ $-716.92K
CA$-511.69K
≈ $-370.15K
0.516x -95.60%
2004-07-31 CA$-117.47K
≈ $-84.98K
CA$-1.38 Million
≈ $-997.57K
11.739x +2050.43%
2002-07-31 CA$1.61 Million
≈ $1.16 Million
CA$-968.11K
≈ $-700.31K
-0.602x +22.24%
2001-07-31 CA$633.46K
≈ $458.24K
CA$-490.32K
≈ $-354.69K
-0.774x --

About Therma Bright Inc

V:THRM Canada Medical Devices
Market Cap
$1.89 Million
CA$2.61 Million CAD
Market Cap Rank
#30172 Global
#1498 in Canada
Share Price
CA$0.05
Change (1 day)
-10.00%
52-Week Range
CA$0.05 - CA$0.11
All Time High
CA$0.87
About

Therma Bright Inc. acquires, develops, manufactures, and markets proprietary healthcare and medical devices focused on respiratory diseases, vascular health, and consumer medical devices for consumer and institutional marketplace. Its products include AcuVid, an antigen and antibody rapid screening test for COVID-19; InterceptCS, a cold sore prevention system, which provides controlled topical he… Read more